Non-alcoholic Fatty Liver Disease

"Non-alcoholic Fatty Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Descriptor ID	D065626
MeSH Number(s)	C06.552.241.519
Concept/Terms	Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease Non alcoholic Fatty Liver Disease NAFLD Nonalcoholic Fatty Liver Disease Fatty Liver, Nonalcoholic Fatty Livers, Nonalcoholic Liver, Nonalcoholic Fatty Livers, Nonalcoholic Fatty Nonalcoholic Fatty Liver Nonalcoholic Fatty Livers Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitides Steatohepatitides, Nonalcoholic Steatohepatitis, Nonalcoholic

Below are MeSH descriptors whose meaning is more general than "Non-alcoholic Fatty Liver Disease".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Fatty Liver [C06.552.241]
Non-alcoholic Fatty Liver Disease [C06.552.241.519]

Below are MeSH descriptors whose meaning is related to "Non-alcoholic Fatty Liver Disease".

Below are MeSH descriptors whose meaning is more specific than "Non-alcoholic Fatty Liver Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Non-alcoholic Fatty Liver Disease" by people in this website by year, and whether "Non-alcoholic Fatty Liver Disease" was a major or minor topic of these publications.

Bar chart showing 73 publications over 15 distinct years, with a maximum of 10 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	0	3	3
2012	0	1	1
2013	0	2	2
2014	3	0	3
2015	7	0	7
2016	3	3	6
2017	2	3	5
2018	2	0	2
2019	4	0	4
2020	7	0	7
2021	8	2	10
2022	8	0	8
2023	6	1	7
2024	6	0	6
2025	1	1	2

Below are the most recent publications written about "Non-alcoholic Fatty Liver Disease" by people in Profiles.

Giri S, Ingawale S, Khatana G, Gore P, Praharaj DL, Wong VW, Huang DQ, Singhal A, Choudhury A. Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021. J Gastroenterol Hepatol. 2025 May; 40(5):1188-1201.

View in: PubMed
Volkert I, Grube J, Woitok MM, Mohamed MR, Edlund K, Duda JC, Dietrich J, Schneider U, Yin G, Lin C, Erschfeld S, Berger H, Candels L, Davis RJ, Bartneck M, K?hnel MP, Guillot A, Schneider KM, Schneider CV, Jonigk D, Rahnenf?hrer J, Tacke F, Hengstler J, Trautwein C. Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency. Hepatology. 2026 Feb 01; 83(2):344-361.

View in: PubMed
Cho EJ, Chung GE, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Yu SJ. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol. 2024 09 12; 23(1):340.

View in: PubMed
Babu Balagopal P, Kohli R, Uppal V, Averill L, Shah C, McGoogan K, Di Guglielmo M, Goran M, Hossain MJ. Effect of N-acetyl cysteine in children with metabolic dysfunction-associated steatotic liver disease-A pilot study. J Pediatr Gastroenterol Nutr. 2024 Sep; 79(3):652-660.

View in: PubMed
Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 05 02; 390(17):1632.

View in: PubMed
Min K, Yenilmez B, Kelly M, Echeverria D, Elleby M, Lifshitz LM, Raymond N, Tsagkaraki E, Harney SM, DiMarzio C, Wang H, McHugh N, Bramato B, Morrison B, Rothstein JD, Khvorova A, Czech MP. Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis. Elife. 2024 Apr 02; 12.

View in: PubMed
Wuopio A, Baker BM, Koethe B, Goodman MD, Shin R, Bugaev N, Nepomnayshy D, Kim WC, Schnelldorfer T. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery? Obes Surg. 2024 03; 34(3):769-777.

View in: PubMed
Fantasia KL, Austad K, Mohanty A, Long MT, Walkey A, Drainoni ML. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and?Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A?Mixed-Methods Evaluation. Endocr Pract. 2024 Mar; 30(3):270-277.

View in: PubMed
Liu H, Li N, Kuang G, Gong X, Wang T, Hu J, Du H, Zhong M, Guo J, Xie Y, Xiang Y, Wu S, Yuan Y, Yin X, Wan J, Li K. Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M. Free Radic Biol Med. 2024 01; 210:42-53.

View in: PubMed
VoPham T, Cravero A, Feld LD, Green P, Feng Z, Berry K, Kim NJ, Vutien P, Mendoza JA, Ioannou GN. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis. Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1069-1078.

View in: PubMed

People

Explore

Similar Concepts

Top Journals